JANUS HENDERSON GROUP PLC

Position in STOK — Stoke Therapeutics, Inc.

CIK 1274173 LONDON, X0

Position in STOK

as of Mar 31, 2026 · filed May 18, 2026 Compact

Position Value

$52,512,149

+$6,459,536 QoQ

Shares Held

1,612,781

+11.2% QoQ

Ownership

2.50%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

9 quarters on record

Voting authority Sole 0% Shared 99% None 1%

Healthcare · as of Mar 31, 2026

JANUS HENDERSON GROUP PLC holds $15,213,180,190 across 182 Biotechnology names. STOK ranks #46 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	2,541,732	$1,856,099,791
2	PRAX	Praxis Precision Medicines, Inc.	3,458,863	$1,114,411,067
3	MDGL	Madrigal Pharmaceuticals, Inc.	2,018,647	$1,056,701,142
4	BBIO	BridgeBio Pharma, Inc.	13,179,013	$978,673,503
5	PCVX	Vaxcyte, Inc.	16,575,875	$963,224,094
6	VRTX	Vertex Pharmaceuticals Inc / Ma	2,131,527	$951,812,064
7	RVMD	Revolution Medicines, Inc.	9,766,496	$949,791,733
8	MIRM	Mirum Pharmaceuticals, Inc.	6,945,813	$641,654,204

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$52,512,149	1,612,781	+11.2%	Shares	Defined	2026-05-18
2025-12-31	$46,052,613	1,450,933	+333.8%	Shares	Defined	2026-02-17
2025-09-30	$7,860,303	334,481	+1669.7%	Shares	Defined	2025-11-14
2025-06-30	$214,515	18,900	0.0%	Shares	Defined	2025-08-14
2025-03-31	$125,685	18,900	0.0%	Shares	Defined	2025-05-15
2024-12-31	$208,467	18,900	0.0%	Shares	Defined	2025-02-14
2024-09-30	$232,281	18,900	0.0%	Shares	Defined	2024-11-14
2024-06-30	$255,339	18,900	-96.4%	Shares	Defined	2024-08-14
2020-03-31	$12,150,488	530,589	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.